Investors & Corporate
Immuron's stock pulls back but still nearly doubles after stock offering
21 July 2020
Shares of Immuron Ltd. IMRN, -2.72% nearly doubled in premarket trading Tuesday, but pulled back sharply from earlier highs, after the Australia-based biopharmaceutical company announced a registered direct offering of 1.07 million American depositary....
Immuron's stock blasts off nearly 10-fold after partner NMRC seeks pre-IND meeting with FDA
9 June 2020
The U.S.-listed shares of Immuron Ltd.  skyrocketed nearly 10-fold on massive volume in afternoon trading Tuesday, after the Australia-based biopharmaceutical company said its research partner, the Naval Medical Research Center (NMRC) has requested.....
Immuron’s shares rise on the back of Travelan® results
12 June 2019
Australian biopharmaceutical group, Immuron Ltd (ASX:IMC; NASDQ:IMRN), has provided an extremely promising update on the company’s cooperative research and development agreements with the US Department of Defence, no doubt contributing to its strong share
Shares in Australian pharma Immuron are going nuts
8 March 2018
Shares in pharmaceutical company Immuron Limited surged by 80% when it announced promising results in testing its anti-inflammation drug. The Australian microbiome is developing and commercialising treatments for inflammatory and infectious diseases.
